Listen to this podcast to discover more about CheckMate-153 study, data from which was presented at this years 2017 ESMO Congress (8–12th September, Madrid, Spain).

You can view more podcasts plus the latest research, news and interviews at www.oncology-central.com

Listen to this podcast to discover more about CheckMate-153 study, data from which was presented at this years 2017 ESMO Congress (8–12th September, Madrid, Spain). You can view more podcasts plus the latest research, news and interviews at www.oncology-central.com

Share OCTalks: Could nivolumab past 1 year improve PFS in pretreated NSCLC?

Sign up to save your podcasts

OCTalks: Could nivolumab past 1 year improve PFS in pretreated NSCLC?

OCTalks: Could nivolumab past 1 year improve PFS in pretreated NSCLC?